Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 2Sarcoma 1Head & Neck 1Endocrine 1CNS 1

Conditions

Thyroid Neoplasms 1Pheochromocytoma 1Paraganglioma 1Neoplastic Syndromes, Hereditary 1Kidney Neoplasms 1Bone Neoplasms 1

Interventions

Ifosfamide 2Filgrastim 2Doxorubicin 2tumor necrosis factor-alpha, CNGRC fusion protein, human 1pentetreotide 1guadecitabine 1gallium Ga 68 dotatate 1fostamatinib 1Radiotherapy 1Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Microscopy, Electron 1Lenalidomide 1Immunotherapy 1Genetic Testing 1Everolimus 1Drug Therapy 1Cyclophosphamide 1Chemotherapy, Adjuvant 1CYT-6091 1Biological Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Kidney Neoplasms × Genetic Testing × Endocrine × Clear all
NCT03160274 2025-10-15

Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions

The University of Texas Health Science Center at San Antonio

Recruiting
2,000 enrolled
CNSEndocrineGenitourinaryHead & NeckSarcoma

Bone Neoplasms, Kidney Neoplasms, Neoplastic Syndromes, Hereditary, Paraganglioma, Pheochromocytoma, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡